• Identification of variants associated with response or resistance to an approved therapy for the patientís disease.
  • Identification of variants associated with response to a therapy associated with another clinical indication.
  • Identification of variants associated with a therapy (s) in clinical development.

A Comprehensive Genomic Test for Solid Tumors

CancerPlex is a next generation DNA sequencing test for solid tumors. The specific coding regions of over 400 known cancer genes are simultaneously determined using a small amount of DNA extracted from tumor samples, including formalin-fixed, paraffin-embedded (FFPE) tissue and cell blocks from fine-needle aspirates or effusions. This analysis is performed in a single assay, simplifying and streamlining the test ordering process, and eliminating time consuming serial testing. Clinically actionable information unique to each patientís tumor is consolidated into a simple report.

CancerPlex reveals missense changes, insertions and deletions, and previously described rearrangements of ALK, RET, and ROS.

CancerPlex sequences more than 1.5 million nucleotides in 435 genes.

How it works
Get started online and submit inquiry form.
We will contact your physician who will receive a Genesis kit.
Use the kit to submit a saliva specimen with your physician who will send it to Genesis.
Within two weeks, you will get a mail that your results are available with your physician.